- Your move, Roche: what next for crenezumab in Alzheimer's?
- What to look out for at the Alzheimer's Association International Conference
- Biomarker study raises hopes for Alzheimer's blood test
- Lilly sets timelines for solanezumab
- PROFILE: Mundipharma's Antony Mattessich on his journey from terror expert to pharma, contrarian-style
- PROFILE: Vas Narasimhan on many Novartis roles, extinction fears and Hilleman influences
JOB OF THE WEEK Promote your job vacancy